Ozempic (semaglutide) injection 1 mg

Ozempic (semaglutide) injection 1 mg

What is Ozempic

Ozempic is a prescription medication containing semaglutide, a GLP‑1 receptor agonist. It mimics the natural GLP‑1 hormone released after eating.

Key actions:

• stimulates insulin release when blood sugar is high
• reduces glucagon secretion, lowering glucose output from the liver
• slows gastric emptying, reducing appetite and increasing satiety
• improves blood glucose control
• supports weight reduction
• lowers the risk of cardiovascular events
• slows the progression of kidney disease in adults with type 2 diabetes

Uses

Ozempic is prescribed for adults to:

• improve blood sugar control in type 2 diabetes
• reduce the risk of heart attack, stroke, and cardiovascular death
• slow the progression of chronic kidney disease

Dosage and Administration

• administered once weekly, subcutaneously
• injection sites: abdomen, thigh, or upper arm (rotate sites weekly)
• use a new sterile needle for each injection
• hold the dose button for several seconds to ensure full delivery
• do not inject intravenously or intramuscularly

Missed Dose

• if less than 5 days have passed, the missed dose may be taken
• if more than 5 days have passed, skip the dose and resume the regular schedule

Storage

• before first use: refrigerate at 2–8°C
• after first use: may be stored at room temperature for up to 56 days
• do not freeze
• avoid direct sunlight and heat
• remove the needle after each injection

Common Side Effects

• nausea
• vomiting
• diarrhea
• abdominal pain
• constipation
• reduced appetite

Serious Risks

• thyroid C‑cell tumors (contraindicated in patients with MTC or MEN‑2)
• pancreatitis
• worsening diabetic retinopathy with rapid glucose improvement
• hypoglycemia when combined with insulin or sulfonylureas
• dehydration and kidney injury
• severe gastrointestinal reactions
• gallbladder disease
• allergic reactions

Additional Guidance

• carry the pen in hand luggage and avoid extreme temperatures
• dispose of used pens and needles in a sharps container
• follow dietary and physical activity recommendations
• consult a healthcare provider before pregnancy or breastfeeding

Summary

Ozempic is a once‑weekly injectable GLP‑1 receptor agonist for type 2 diabetes. It improves glucose control, reduces cardiovascular risks, and slows kidney disease progression. Proper administration, storage, and awareness of contraindications and side effects are essential for safe and effective use.